Hefei Lifeon Pharmaceutical Co Ltd (003020) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hefei Lifeon Pharmaceutical Co Ltd (003020) has a cash flow conversion efficiency ratio of 0.343x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥667.63 Million ≈ $97.69 Million USD) by net assets (CN¥1.95 Billion ≈ $284.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hefei Lifeon Pharmaceutical Co Ltd stock valuation for the company's overall valuation and market capitalisation.
Hefei Lifeon Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Hefei Lifeon Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hefei Lifeon Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hefei Lifeon Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Hefei Lifeon Pharmaceutical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Taiwan Sakura Corp
TW:9911
|
0.059x |
|
Healthcare Co Ltd
SHG:603313
|
0.109x |
|
Cuckoo Electronics Co Ltd
KO:192400
|
0.022x |
|
Rashi Peripherals Limited
NSE:RPTECH
|
0.017x |
|
Sichuan Xichang Electric Power Co Ltd
SHG:600505
|
0.101x |
|
Obrascon Huarte Lain SA
MC:OHLA
|
0.289x |
|
Quess Corp Limited
NSE:QUESS
|
0.136x |
|
RVRC Holding AB
ST:RVRC
|
0.014x |
Annual Cash Flow Conversion Efficiency for Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2025. View Hefei Lifeon Pharmaceutical Co Ltd (003020) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.95 Billion ≈ $285.59 Million |
CN¥212.89 Million ≈ $31.15 Million |
0.109x | +5.62% |
| 2024-12-31 | CN¥1.91 Billion ≈ $279.87 Million |
CN¥197.53 Million ≈ $28.91 Million |
0.103x | -5.00% |
| 2023-12-31 | CN¥1.87 Billion ≈ $274.15 Million |
CN¥203.67 Million ≈ $29.80 Million |
0.109x | -19.80% |
| 2022-12-31 | CN¥1.48 Billion ≈ $216.60 Million |
CN¥200.64 Million ≈ $29.36 Million |
0.136x | +11.37% |
| 2021-12-31 | CN¥1.30 Billion ≈ $190.80 Million |
CN¥158.70 Million ≈ $23.22 Million |
0.122x | -17.16% |
| 2020-12-31 | CN¥1.17 Billion ≈ $171.79 Million |
CN¥172.49 Million ≈ $25.24 Million |
0.147x | -41.94% |
| 2019-12-31 | CN¥590.00 Million ≈ $86.34 Million |
CN¥149.30 Million ≈ $21.85 Million |
0.253x | +98.55% |
| 2018-12-31 | CN¥505.70 Million ≈ $74.00 Million |
CN¥64.45 Million ≈ $9.43 Million |
0.127x | +307.11% |
| 2017-12-31 | CN¥361.71 Million ≈ $52.93 Million |
CN¥11.32 Million ≈ $1.66 Million |
0.031x | -84.18% |
| 2016-12-31 | CN¥298.09 Million ≈ $43.62 Million |
CN¥58.99 Million ≈ $8.63 Million |
0.198x | -53.66% |
| 2014-12-31 | CN¥215.53 Million ≈ $31.54 Million |
CN¥92.05 Million ≈ $13.47 Million |
0.427x | +112.57% |
| 2013-12-31 | CN¥176.88 Million ≈ $25.88 Million |
CN¥35.54 Million ≈ $5.20 Million |
0.201x | +458.44% |
| 2012-12-31 | CN¥141.96 Million ≈ $20.77 Million |
CN¥-7.96 Million ≈ $-1.16 Million |
-0.056x | -- |
About Hefei Lifeon Pharmaceutical Co Ltd
Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethy… Read more